Stay updated on AZD4785 Phase I Dose-Escalation Clinical Trial
Sign up to get notified when there's something new on the AZD4785 Phase I Dose-Escalation Clinical Trial page.

Latest updates to the AZD4785 Phase I Dose-Escalation Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe clinical trial record for AZD4785 is displayed in place of the 403 error screen, showing the study details and related information.SummaryDifference47%

- Check15 days agoChange DetectedThe site revision label changed from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check22 days agoChange DetectedA site-wide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the unchanged 403 error for the study record.SummaryDifference1%

- Check29 days agoChange DetectedThe site revision label in the footer changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check36 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check57 days agoChange DetectedThe page now shows a 403 Forbidden error and minimal header elements, instead of displaying the full study record content.SummaryDifference18%

Stay in the know with updates to AZD4785 Phase I Dose-Escalation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AZD4785 Phase I Dose-Escalation Clinical Trial page.